Literature DB >> 8408632

Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo.

D C Rockey1, C N Housset, S L Friedman.   

Abstract

Hepatic lipocytes are perisinusoidal cells that have been thought to be analogous to tissue pericytes, a cell type with purported vasoregulatory properties. However, we and others have recently demonstrated that lipocytes acquire markers of smooth muscle cells or myofibroblasts only after liver injury, via a process termed "activation." In this study, we document lipocyte contractility on collagen lattices and examine the importance of activation in this process. In culture, lipocytes became contractile only after spreading and activating, coincident with expression of smooth muscle alpha actin, a marker of activation (1990. Virchows Arch. B Cell Pathol. 59:349). After 5 d in culture, lipocytes induced rapid and sustained contraction of collagen lattices (to 43.7 +/- 2.3% of their original size 24 h after detachment). There was no contraction of lattices containing hepatocytes. Scanning electron microscopy demonstrated intimate associations of lipocyte cell membranes and collagen fibrils. Reduction in cell volume during contraction was also prominent. Lattice contraction by lipocytes was proportional to cell number. Serum was a potent stimulator of lipocyte contraction, as were endothelin types 1, 2, and 3; the effect of serum and endothelin 1 were additive. Neither thrombin, angiotensin-II, serotonin, nor the cytokines PDGF and TGF beta induced contraction. Cytochalasin B treatment resulted in concentration-dependent inhibition of contraction. As a test of the in vivo relevance of the culture findings, lipocytes were isolated from fibrotic animals and examined immediately after adherence. Whereas lipocytes from normal liver were initially compact, smooth muscle alpha actin negative and noncontractile, cells from animals with hepatic injury due to CCl4 displayed an activated appearance, expressed smooth muscle alpha actin, and were contractile immediately after adherence. Additionally, IFN-gamma, an agent which blocks lipocyte activation (1992. Hepatology. 16:776), inhibited lipocyte contraction. The data document that normal (i.e., quiescent) lipocytes are not contractile, but that activation is associated with the development of contractility. These findings suggest that a role for lipocytes in organ contraction or vasoregulation may be confined to injured, not normal liver.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408632      PMCID: PMC288342          DOI: 10.1172/JCI116769

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

Review 1.  Nerves and perisinusoidal cells in human liver.

Authors:  P Bioulac-Sage; M E Lafon; J Saric; C Balabaud
Journal:  J Hepatol       Date:  1990-01       Impact factor: 25.083

2.  Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction.

Authors:  G Gabbiani; G B Ryan; G Majne
Journal:  Experientia       Date:  1971-05-15

3.  Ultrastructure of mammalian venous capillaries, venules, and small collecting veins.

Authors:  J A Rhodin
Journal:  J Ultrastruct Res       Date:  1968-12

4.  Comparative studies of collagen lattice contraction utilizing a normal and a transformed cell line.

Authors:  D J Buttle; H P Ehrlich
Journal:  J Cell Physiol       Date:  1983-08       Impact factor: 6.384

5.  "Sternzellen" in the liver: perisinusoidal cells with special reference to storage of vitamin A.

Authors:  K Wake
Journal:  Am J Anat       Date:  1971-12

6.  Purified rat liver fat-storing cells in culture divide and contain collagen.

Authors:  A M de Leeuw; S P McCarthy; A Geerts; D L Knook
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

7.  Contractile fibroblasts in chronic alcoholic cirrhosis.

Authors:  R Rudolph; W J McClure; M Woodward
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

8.  Vitamin A-containing lipocytes and formation of type III collagen in liver injury.

Authors:  G Kent; S Gay; T Inouye; R Bahu; O T Minick; H Popper
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

9.  Immunocytochemical detection of desmin in fat-storing cells (Ito cells).

Authors:  Y Yokoi; T Namihisa; H Kuroda; I Komatsu; A Miyazaki; S Watanabe; K Usui
Journal:  Hepatology       Date:  1984 Jul-Aug       Impact factor: 17.425

Review 10.  Intermediate filaments.

Authors:  P M Steinert; J C Jones; R D Goldman
Journal:  J Cell Biol       Date:  1984-07       Impact factor: 10.539

View more
  63 in total

Review 1.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.

Authors:  H Reynaert; M G Thompson; T Thomas; A Geerts
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 2.  Targeting collagen expression in alcoholic liver disease.

Authors:  Kyle J Thompson; Iain H McKillop; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

3.  Smooth muscle α actin is specifically required for the maintenance of lactation.

Authors:  Nate Weymouth; Zengdun Shi; Don C Rockey
Journal:  Dev Biol       Date:  2011-11-12       Impact factor: 3.582

4.  NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension.

Authors:  S Fiorucci; E Antonelli; O Morelli; A Mencarelli; A Casini; T Mello; B Palazzetti; D Tallet; P del Soldato; A Morelli
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

5.  Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells.

Authors:  Hendrik Reynaert; Krista Rombouts; Yutao Jia; Daniel Urbain; Nirjhar Chatterjee; Naoki Uyama; Albert Geerts
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

6.  Aortic carboxypeptidase-like protein is expressed in fibrotic human lung and its absence protects against bleomycin-induced lung fibrosis.

Authors:  Scott L Schissel; Sarah E Dunsmore; Xiaoli Liu; Robert W Shine; Mark A Perrella; Matthew D Layne
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

7.  Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2.

Authors:  Hitoshi Ikeda; Naoko Watanabe; Isao Ishii; Tatsuo Shimosawa; Yukio Kume; Tomoaki Tomiya; Yukiko Inoue; Takako Nishikawa; Natsuko Ohtomo; Yasushi Tanoue; Satoko Iitsuka; Ryoto Fujita; Masao Omata; Jerold Chun; Yutaka Yatomi
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

8.  Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.

Authors:  Hong-Qiang Feng; Nate D Weymouth; Don C Rockey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

9.  Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia.

Authors:  G A Ramm; V G Nair; K R Bridle; R W Shepherd; D H Crawford
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

Review 10.  Stellate cell contraction: role, regulation, and potential therapeutic target.

Authors:  Russell K Soon; Hal F Yee
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.